The TARGET (TPMT: Azathioprine Response to Genotyping and Enzyme Testing) study

William G. Newman; Kenna D. Payne; Kay Poulton; Joel Andrews; Brian A. Houston; Rachel Elliott; RG Elles; DW Ray; Jon Shaffer; Christopher Em Griffiths; Ian N Bruce; Stephen A. Roberts; F Qasim; Wer Ollier

Related publications

Article2011

A Pragmatic Randomized Controlled Trial of Thiopurine Methyltransferase Genotyping Prior to Azathioprine Treatment: the TARGET Study

William G. Newman, Katherine Payne, Karen Tricker, Stephen A. Roberts, Emily Fargher, Sudeep Pushpakom, Jane Alder, Gary P Sidgwick, Debbie Payne, Rachel Elliott, Marco Heise, R Elles, Simon Ramsden, J. Andrews, J. Brian Houston, Jon Shaffer, Christopher Em Griffiths, David Ray, Ian N Bruce, William Ollier

Article2004

Response to “Athletes Genotyping: Ethical and Legal Issues”

Ingrid B. Borecki, Ping An, Tuomo Rankinen, Louis Pérusse, A. S. Leon, J. S. Skinner, Wilmore Jh, Claude Bouchard, D. C. Rao

International Journal of Sports Medicine

Article2010

Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens

Katy Bell, Andrew Hayen, Petra Macaskill, Jonathan C. Craig, Bruce Neal, Kim Fox, Willem J. Remme, Folkert W. Asselbergs, Wiek H. van Gilst, Stephen MacMahon, Giuseppe Remuzzi, Piero Ruggenenti, Koon Teo, Les Irwig

Article1995

RESPONSE OF SKELETAL MUSCLE ENZYME ACTIVITIES TO ENDURANCE TRAINING: VARIATION WITHIN AND BETWEEN FAMILIES.

J. A. Simoneau, Jacques Gagnon, G Thériault, A. S. Leon, D. C. Rao, James S. Skinner, Jack H. Wilmore, Claude Bouchard

Medicine & Science in Sports & Exercise

Letter2015

Response to Perner et al.: testing current practice is no mistake

Jean Louis Vincent, Jesse B. Hall, Arthur S. Slutsky